Lv1
30 积分 2025-05-20 加入
Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials
1天前
已完结
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis
1天前
已完结
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond
1个月前
已完结
Impact of NAFLD and Fibrosis on Adverse Cardiovascular Events in Patients With Hypertension
5个月前
已完结
皖公网安备34019202002308
